Chemistry:Methylenedioxyallylamphetamine
From HandWiki
Methylenedioxyallylamphetamine (MDAL or 3,4-methylenedioxy-N-allylamphetamine) is a lesser-known drug.[1][2][2] It is the N-allyl derivative of 3,4-methylenedioxyamphetamine (MDA).[1][2]
Use and effects
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MDAL's minimum dose as 180 mg orally and its duration as unknown.[1][2] MDAL produces few to no effects on its own, but may enhance the effects of psychedelic drugs like LSD.[1]
Chemistry
Synthesis
The chemical synthesis of MDAL has been described.[1]
Society and culture
Legal status
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[3]
See also
- Substituted methylenedioxyphenethylamine
- Phenylpropylaminopentane
- MDPR
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. http://www.erowid.org/library/books_online/pihkal/pihkal.shtml. MDAL entry
- ↑ 2.0 2.1 2.2 2.3 "Basic Pharmacology and Effects". Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. 2003. pp. 67–137. ISBN 978-0-12-433951-4. https://bibliography.maps.org/resources/download/12634.
- ↑ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. http://isomerdesign.com/Cdsa/scheduleUK.php?schedule=1&ion=30&structure=C. Retrieved 12 March 2014.
External links
 |  |
